37 examiners • 17 with pending office actions • Biotechnology & Pharmaceuticals (Tech Center 1600)
| Examiner | Allowance rate | Resolved cases | Pending apps |
|---|---|---|---|
| Kara D Johnson | 75.8% | 260 | 21 |
| Marcia Stephens Noble | 67.1% | 858 | 36 |
| Teresa E Knight | 65.0% | 117 | 0 |
| David A Montanari | 64.7% | 771 | 41 |
| Valarie E Bertoglio | 64.1% | 868 | 28 |
| Deborah Crouch | 62.9% | 377 | 0 |
| Shin Lin Chen | 62.7% | 818 | 0 |
| Titilayo Moloye | 62.3% | 555 | 36 |
| Briana Noel Ebbinghaus | 59.2% | 76 | 36 |
| Emily Ann Cordas | 57.8% | 301 | 31 |
| Maytee Marie Contes De Jesus | 56.2% | 48 | 0 |
| Taeyoon Kim | 56.0% | 150 | 0 |
| Thaian N Ton | 50.5% | 535 | 0 |
| Lauren K Van Buren | 50.4% | 125 | 0 |
| Anne Marie Falk | 45.9% | 181 | 0 |
| Magdalene K Sgagias | 45.1% | 475 | 0 |
| Khoa Nhat Tran | 43.8% | 89 | 29 |
| Anoop Kumar Singh | 43.0% | 721 | 45 |
| Matasha Dhar | 42.9% | 91 | 29 |
| Constantina E Stavrou | 41.8% | 91 | 43 |
| Michael C Wilson | 34.6% | 743 | 0 |
| Joanne Hama | 32.0% | 128 | 0 |
| Laura J Schuberg | 30.6% | 111 | 0 |
| Gillian Chelsea Reglas | 30.2% | 63 | 35 |
| Wu Cheng Winston Shen | 29.9% | 147 | 0 |
| Risa Takenaka | 27.3% | 22 | 22 |
| Alexandra F Connors | 26.9% | 26 | 0 |
| Suzanne E Ziska | 26.3% | 38 | 0 |
| Chi-Feng Hsu | 26.2% | 61 | 0 |
| Zanna Maria Beharry | 25.0% | 72 | 41 |
| Austin Michael Jeffries | 20.0% | 5 | 0 |
| Peter Paras Jr. | 10.2% | 59 | 0 |
| Joseph Paul Miano | 0.0% | 4 | 0 |
| Eric Brandon Wright | 0.0% | 1 | 22 |
| Hannah Sarah Philipose | 0.0% | 1 | 0 |
| Hashanthi Komitige Abeyratne-Perera | 0.0% | 1 | 17 |
| Arman Mahmood Farazdaghi | — | 0 | 6 |
38.2% over the last five years, across 4,073 resolved applications.
Among examiners with at least 30 resolved applications: Kara D Johnson (75.8%, 260 resolved), Marcia Stephens Noble (67.1%, 858 resolved), Teresa E Knight (65.0%, 117 resolved).
Among examiners with at least 30 resolved applications: Peter Paras Jr. (10.2%, 59 resolved), Zanna Maria Beharry (25.0%, 72 resolved), Chi-Feng Hsu (26.2%, 61 resolved).